<DOC>
	<DOCNO>NCT03062566</DOCNO>
	<brief_summary>The PreTBI III study aim investigate prognostic potential prehospital repeat in-hospital S100B , NSE GFAP measurement predictor neurological outcome patient suffer severe TBI . Knowledge prehospital S100B , GFAP NSE level predictor neurological outcome mortality may underline potential point-of-care analysis . Possibly , early biomarker level may contribute accurate monitoring biomarker dynamic hereby support neurosurgeon anaesthetists clinical decision-making regard treatment level care offer patient . Hypotheses : 1 . Prehospital S100B level significant predictor unfavourable neurological outcome ( dichotomized disability rating scale ( DRS ) glasgow outcome scale extend ( GOS-E ) measure ) severe TBI patient . 2 . Prehospital GFAP level significant predictor unfavourable neurological outcome ( dichotomize DRS GOSE measure ) severe TBI patient . 3 . Prehospital NSE level significant predictor unfavourable neurological outcome ( dichotomize DRS GOSE measure ) severe TBI patient . 4. combined panel prehospital S100B , GFAP NSE level significant predictor unfavourable neurological outcome ( dichotomize DRS GOSE measure ) severe TBI patient . 5 . Unfavourable neurological outcome ( dichotomize DRS GOSE measure ) severe TBI patient predict dynamic repeat measurement S100B , GFAP NSE .</brief_summary>
	<brief_title>Prognostic Potential Prehospital Biomarkers TBI Patients</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Patients present Glasgow Coma Score ( GCS ) GCS 38 suffer relevant trauma display relevant clinical index compatible TBI evaluate EMS staff . Patients consider incompetent due ongoing alteration mental state . &gt; 6 hour elapse trauma , unknown time trauma , multi trauma , know dementia , chronic psychosis active central nervous system ( CNS ) pathology .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>biomarkers</keyword>
	<keyword>point-of-care analysis</keyword>
</DOC>